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a b s t r a c t
For years, there have been studies based on the use of natural compounds plant-derived as potential
therapeutic agents for various diseases in humans. Curcumin is a phenolic compound extracted from
Curcuma longa rhizome commonly used in Asia as a spice, pigment and additive. In traditional medicine
of India and China, curcumin is considered as a therapeutic agent used in several foods. Numerous
studies have shown that curcumin has broad biological functions particularly antioxidant and antiin-
ﬂammatory. In fact, it has been established that curcumin is a bifunctional antioxidant; it exerts
antioxidant activity in a direct and an indirect way by scavenging reactive oxygen species and inducing
an antioxidant response, respectively. The renoprotective effect of curcumin has been evaluated in
several experimental models including diabetic nephropathy, chronic renal failure, ischemia and
reperfusion and nephrotoxicity induced by compounds such as gentamicin, adriamycin, chloroquine,
iron nitrilotriacetate, sodium ﬂuoride, hexavalent chromium and cisplatin. It has been shown recently in
a model of chronic renal failure that curcumin exerts a therapeutic effect; in fact it reverts not only
systemic alterations but also glomerular hemodynamic changes. Another recent ﬁnding shows that the
renoprotective effect of curcumin is associated to preservation of function and redox balance of
mitochondria. Taking together, these studies attribute the protective effect of curcumin in the kidney
to the induction of the master regulator of antioxidant response nuclear factor erythroid-derived 2
(Nrf2), inhibition of mitochondrial dysfunction, attenuation of inﬂammatory response, preservation of
antioxidant enzymes and prevention of oxidative stress. The information presented in this paper
identiﬁes curcumin as a promising renoprotective molecule against renal injury.
& 2013 The Authors. Published by Elsevier B.V.
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Introduction
History and cultivation of Curcuma longa
Curcuma longa (turmeric or curcuma) is a rhizomatus mono-
cotyledonous perennial herbaceous plant member of the ginger
family (Zingiberaceae), endemic and prevalent in tropical and
subtropical regions including India, China and South East Asia.
India is the most important producer, consumer and exporter of
turmeric. Its Latin name Curcuma, is derived from the Arabic word,
Kourkoum, the original name for saffron [16]. C. longa and its
growth requires a hot, humid climate with temperatures between
20 and 30 1C and great amounts of water [29]. Turmeric has long
been known as a spice, remedy and dye, and since 1280, Marco
Polo mentioned turmeric in his travel around China and India.
In the 13th century, Arabian merchants brought turmeric to the
European market from India. During the British settlement of India
in the 15th century, turmeric was combined with several other
spices to form curry powder.
Curcuminoids and curcumin
Curcuma contains 60–70% carbohydrate, 8.6% protein, 5–10%
fat, 2–7% ﬁber, 3–5% curcuminoids (50–70% curcumin) and up to
5% essential oils and resins. The curcuminoid content in turmeric
may vary between 2 and 9%, depending on geographical condi-
tions [29]. The composition of curcuminoids is approximately 70%
curcumin (curcumin I), 17% demethoxycurcumin (curcumin II),
3% bis-demethoxycurcumin (curcumin III) and the rest (10%) is
called cyclocurcumin (curcumin IV) [5,8,36] (Fig. 1). However, the
last compound has been associated with poor or non-biological
activity [61]. The most active component of turmeric is curcumin
[67]; Vogel ﬁrst isolated it in 1815 [29]. Curcumin is an orange–
yellow crystalline powder practically insoluble in water. The
structure of curcumin (Fig. 1) was ﬁrst described in 1910 by Lampe
and Milobedeska and proved to be diferuloylmethane [29]. Studies
indicate that functional groups associated to curcumin chemical
structure including bis-α,βunsaturated β-diketone, two methoxy
groups, two phenolic hydroxy groups and two double-conjugated
Fig. 1. Chemical structures and abundance of curcuminoids in turmeric that have terapeutic effects.
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bonds might play an essential role in antiproliferative and anti-
inﬂammatory activities assigned to curcumin [3]. Curcumin has
keto-enol tautomers, of which keto form predominates in acid and
neutral solutions and enol form in alkaline solutions.
Curcumin as a food additive
Turmeric is an ingredient of spice blends, mainly curry powder,
which generally consists of turmeric, clove, paprika, ginger, cardamom,
coriander, cumin, mace, pepper and cinnamon. Turmeric is commonly
used as natural pigment (yellow 3) in the cosmetic and textile
production but it is widely used in food industry. Indeed, turmeric is
classiﬁed as an additive in E100 category and is used as food color
additive in mustard, pastries, daily products and canned ﬁsh [40].
Furthermore, according to the Joint FAO/WHO Expert Committee on
Food Additives (JECFA) the admissible daily intake (ADI) is 0–3mg/kg
body weight and it was established at the 61st JECFA in 2003 [29].
Curcumin: Traditional uses in folk medicine and biological properties
Curcuminoids have been consumed as therapeutic infusions
over the centuries worldwide. In Ayurvedic medicine, curcumin is
a well-documented treatment for various respiratory conditions
such as, asthma, bronchial hyperactivity and allergy, as well as for
liver disorders, anorexia, rheumatism, diabetic wounds, runny nose,
cough and sinusitis [10]. In traditional Chinese medicine curcumin
has been used to treat diseases associated with abdominal pain
[35]. In ancient Hindu medicine, it was used to treat sprains and
swelling [10]. In Oriental cultures, it has traditionally been used as
good therapeutic alternative, particularly as an anti-inﬂammatory,
antioxidant, anticarcinogenic and antimicrobial reagent. In fact, it
has scientiﬁcally proven that curcumin is indeed antioxidant
[11,31,26,17], anti-inﬂammatory [2,82,86], and antibacterial [52].
Moreover, it has also been used because of its hepatoprotective
[56,32,86], thrombosuppressive, neuroprotective [85,18,63], cardio-
protective [37,23,73], antineoplasic [4,17,68], antiproliferative [12],
hypoglycemic and antiarthritic effect [35]. Curcumin has also been
used for the treatment of intestinal parasites and as a remedy for
poisoning, snakebites and various other complaints [49]. In this
review we are focused on the renoprotective effects of curcumin
and the mechanisms involved in this effect.
Antioxidant properties of curcumin
Oxidative stress plays a major role in the pathogenesis of
various diseases including myocardial ischemia, cerebral brain
ischemia-reperfusion injury, hemorrhage and shock, neuronal
cell injury, hypoxia and cancer. Curcuminoids exhibit a differential
antioxidant activity in several in vitro and in vivo models, for
example, preventing lipid peroxidation in a variety of cells such
as erythrocytes, rat brain homogenates, rat liver microsomes,
liposomes and macrophages, where peroxidation is induced by
Fenton's reagent, as well as for metals, hydrogen peroxide (H2O2)
and 2,2′-azo-bis(2-amidino-propane) hydrochloride (AAPH) [62].
Furthermore, it has been reported that curcumin is a bifunc-
tional antioxidant [26] because of its ability to react directly
with reactive species and to induce an up-regulation of various
cytoprotective and antioxidant proteins. Curcumin is able to sca-
venge superoxide anion (O2
̄∙) [6,76], hydroxyl radicals (∙OH) [13],
H2O2, [6,13], singlet oxygen [25], nitric oxide [77,78], peroxynitrite
[44] and peroxyl radicals (ROO∙) [13]. Together, these mechanisms
might explain, at least in part, some of the cytoprotective effects of
this compound. Features as the presence of phenolic groups in the
structure of curcumin (Fig. 1) explains its ability to react with
reactive oxygen species (ROS) and reactive nitrogen species (RNS)
and might probably be one of the mechanisms through which
curcumin treatment protects the epithelial cells of renal tubules
(LLC-PK1) from oxidative damage induced by H2O2 [22].
The indirect antioxidant capacity of curcumin is deﬁned by its
ability to induce the expression of cytoprotective proteins such as
superoxide dismutase (SOD), catalase (CAT) [59], glutathione reduc-
tase (GR), glutathione peroxidase (GPx) [87], heme oxygenase 1
(HO-1) [42,63], glutathione-S-transferase (GST), NAD(P)H: quinone
oxidoreductase 1 (NQO1) [88] and γ-glutamylcysteine ligase (γGCL)
[65]. Furthermore, it has been reported that curcumin can increase
the synthesis and concentration of reduced glutathione (GSH) in
astrocytes and neurons by induction of γGCL [47]. The cytoprotec-
tive proteins induced by curcumin are regulated by the nuclear
factor erythroid-derived 2 (Nrf2, [24,64]), which in turns is also
activated by curcumin [17,28]. On the other hand, it is well known
that encoding genes for cytoprotective proteins are induced coordi-
nately by a common molecular mechanism in which the inductors
highly modify reactive thiol groups of cysteine in the Kelch-Like
ECH-Associated Protein 1 (Keap1) [27]. Keap1 protein is a zinc
metalloprotein cysteine-rich bound to Nrf2 and normally associated
with the protein complex cullin 3 (CuI3), which promotes the
ubiquitination and subsequent proteosomal degradation, prevent-
ing Nrf2 translocation into the nucleus. Also, it was established that
the gene expression of cytoprotective proteins is regulated by three
cellular components: (i) Antioxidant response element (ARE)
sequence, a speciﬁc sequence present in regulatory regions of the
genes of cytoprotective proteins, (ii) Nrf2, a transcription factor
consisting of a basic leucine zipper that regulates basal and
inducible expression of cytoprotective genes, and (iii) Keap1, the
chemical sensor for inductors. In general, the cysteine residues
interaction of protein-Keap1 with some compounds induces con-
formational changes that abrogate the ability of Keap1 to repress
Nrf2; this transcription factor migrates to the nucleus where it is
combined with small Maf transcription factors. This complex binds
to ARE facilitating the transcription of cytoprotective gene. By this
reason, Nrf2 is considered a master regulator of the antioxidant
response against oxidative stress.
Renal diseases epidemiology
The homeostasis of body extracellular electrolyte composition
and ﬂuid volume is essential for all animals and humans to
survive. The kidney plays a fundamental role in maintaining
precise body and/or extracellular electrolyte, ﬂuid balance and
blood pressure homeostasis primarily through the actions of its
proximal and distal tubular segments of nephrons [38]. Under
renal insufﬁciency conditions, deregulation of extracellular elec-
trolytes or overall ﬂuids volume may lead to disturbance of the
circulation, including cardiac output and blood pressure [39].
Prevalence of chronic kidney disease is estimated to be 8–16%
worldwide [43] and it is expected that the number of patients with
chronic kidney disease increase at a fastest rate in the poorest
parts of the world. According to the 2010 Global Burden of Disease
Study, chronic kidney disease was ranked 27th in the list of causes of
total number of global deaths in 1990, but rose to 18th in 2010 [48].
Patients with chronic kidney disease are at an increase risk of acute
kidney injury (AKI). Acute kidney injury might occur with the use of
several drugs, such as non-esteroidal anti-inﬂammatory drugs, anti-
biotics, antineoplastic drugs, and angiotensin-converting-enzyme
inhibitors. A meta-analysis of 13 cohort studies conﬁrmed that AKI
is an important risk factor for chronic and end-stage renal disease
[21]. Severe, long, and repeated episodes of acute kidney injury
increase the risk of progression of chronic kidney disease. Acute and
chronic renal failures are global public health issues with different
features to take into account in different parts of the world, renal
complications, which involve most organ systems, can be treated and
prevented, by using different therapeutic strategies.
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Renoprotective effect of curcumin
Renal injury induced by diabetes
Diabetic nephropathy (DN) is one of the main causes of end-
stage renal disease. DN is characterized by the presence of
hyperﬁltration, glomerular hypertrophy, tubular albuminuria,
mesangial matrix expansion, and increased expression of extra-
cellular matrix proteins that involves several proﬁbrotic factors
such as transforming growth factor β (TGF-β) and connective tissue
growth factor (CTGF). The effect of curcumin on diabetic nephro-
pathy has been studied [75]. Sharma et al. [69] have been found
that curcumin administration (15 and 30 mg/kg/day for two
weeks) protects against streptozotocin-induced diabetic nephro-
pathy and oxidative stress. Furthermore, Soetikno et al. [72]
evaluated in a diabetic nephropathy model the effect of oral
curcumin administration (100 mg/kg/day for 8 weeks) showing
that curcumin prevents progression of renal disease.
Curcumin treatment attenuates proteinuria and improves creati-
nine clearance after 3 weeks of streptozotocin injection. In addition,
it decreased oxidative stress by reducing levels of subunits of
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase
Nox4 and p67phox, which catalyzes the synthesis of O2 ∙. Moreover,
it also increased the activity of the antioxidant enzyme GPx.
The renoprotective effect of curcumin was related to the down-
regulation of the proﬁbrotic cytokines vascular endothelial growth
factor (VEGF), TGF-β, CTGF and osteopontin as well as in extracellular
matrix proteins ﬁbronectin and collagen IV. Moreover, it was
observed a reduction in the development of structural damage
evidenced by lower glomerulosclerosis index (GS), tubulointerstitial
(IT) ﬁbrosis and arteriolopathy. These effects might be in part
mediated by inhibition of protein kinase C-β (PKC-β), kinase respon-
sible for the phosphorylation of a wide diversity of proteins [72].
Cellular events such as inhibition of nuclear factor kappa-light-chain-
enhancer of activated B cells (NF-κB) [20,71] and decrease of
macrophage inﬁltration [71], histone acetyltransferase p300 protein
and oxidative stress [20], also have been involved in the mechanisms
through curcumin protects against diabetic nephropathy. Further-
more, the protective effect of curcumin in diabetic nephropathy has
also been associated to the prevention of kidney triglycerides buildup
[74]. Interestingly, curcumin also mitigates cardiac [73] and cerebral
[46] complications in streptozotocin-induced diabetes.
Curcumin derivatives have also been proved to be effective
in ameliorating diabetic nephropathy. Pan et al. [58,57] studied
the effect of curcumin B06 and C66 analogues in diabetic rats
(0.2, 1 and 5 mg/kg/day for 6 weeks) [57,58]. B06 treatment
reduced the inﬂammatory kidney response by the attenuation of
(a) renal macrophage inﬁltration, (b) expression of the proﬁbrotic
cytokine TGF-β, inducible nitric oxide synthase (iNOS), and
cyclooxygenase-2 (COX-2) and (c) the proinﬂammatory cytokines
such as tumor necrosis factor-alpha (TNF-α) and monocyte
chemoattractant protein-1 (MCP-1). The anti-inﬂammatory effect
of B06 was associated with the inhibition of c-Jun N-terminal
kinase (JNK)/NF-κB activation [58,57]. Similarly, the oral adminis-
tration (80 mg/kg/day for 45 days) of tetrahydrocurcumin (THU),
another curcumin derivative, attenuated the renal and hepatic
dysfunction found in rats with diabetes induced by streptozotocin
and nicotinamide [53].
Renal injury induced by 5/6 nephrectomy
The study of chronic progressive renal injury in rats as the 5/6
nephrectomy (5/6NX), which involves the removal of 5/6 of the
renal mass, is useful in the evaluation of strategies to reduce renal
injury. This model is characterized by proteinuria, hypertension,
proliferation of smooth muscle cells of the glomerular arterioles
(arteriolopathy), IT inﬂammation and hemodynamic alterations in
individual nephrons [79].
In 5/6NX renal injury model, Ghosh et al. [33] found that
curcumin (75 mg/kg/day for 8 weeks) exerted a renoprotective
effect associated with the attenuation of inﬂammation, macro-
phage inﬁltration and the high levels of TNF-α in plasma and
kidney and also of renal NF-κB activation [33]. Further studies in
this model by Tapia et al. [79] evaluated the renoprotective effect
of curcumin (60 mg/kg for 37 days). Nephrectomized animals
developed hypertension, proteinuria, increase in serum creatinine
and blood urea nitrogen (BUN) and glomerular hemodynamic
alterations including hyperﬁltration (high single nephron glomer-
ular ﬁltration rate and single nephron glomerular plasma ﬂow),
glomerular hypertension (high glomerular capillary pressure) and
decrease in the afferent and efferent resistances as well as renal
injury characterized by GS and IT ﬁbrosis and inﬂammation.
Interestingly, after curcumin administration, all the above systemic
and glomerular alterations were attenuated. This was the ﬁrst
work showing that curcumin is able to prevent glomerular
hemodynamic alterations secondary to 5/6NX (Fig. 2). The protec-
tive effect of curcumin in this experimental model was associated
to an increased activity of the antioxidant enzymes CAT, GPx, GR,
GST and SOD and a decrease in oxidative stress. Additionally,
Soetikno et al. [70] found that curcumin administration (75 mg/kg/
day for 8 weeks) in 5/6NX rats could reduce proteinuria, systolic
blood pressure, GS, IT damage and inﬂammatory markers as TGF-β,
TNF-α, NF-κB and COX-2. They also found that curcumin attenu-
ated malondialdehyde (MDA) levels (a lipid peroxidation marker)
which was associated with lower expression of p67phox and
p22phox, essential subunits of NADPH oxidase [70]. Both studies
conducted by Tapia et al. [79,80] established that the protective
mechanism achieved by curcumin in the kidney was mainly due to
the nuclear translocation of Nrf2. Later, Tapia et al. [80] showed
that curcumin postreatment (120 mg/kg for 30 days), given 30
days after the 5/6NX induction, was able to revert renal damage
and oxidative stress. These experiments show that curcumin is a
therapeutic agent in experimental chronic renal failure. It is
important to highlight that tissue injury throwback effect of
curcumin turns this molecule into a promising therapeutic agent.
In this regard, it is also remarkable that curcumin can protect not
only against renal injury but also against adverse effects derived
from 5/6NX. For example, Correa et al. [23] showed that curcumin
Fig. 2. Curcumin prevents renal hemodynamic alterations. Curcumin ameliorates
5/6NX-induced alterations in mean arterial pressure (MAP), proteinuria and
glomerular ﬁltration rate (GFR) and in the following parameters of renal hemody-
namics: single-nephron glomerular ﬁltration rate (SNGFR), single-nephron plasma
ﬂow (Qa), glomerular capillary pressure (PGc), afferent resistance (AR) and efferent
resistance (ER).
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(120 mg/kg/day for 67 days) protects against cardiovascular dis-
orders and cardiac tissue remodeling associated to the develop-
ment of chronic renal failure in rats with 5/6NX. The
cardioprotective effect of curcumin in 5/6NX model was associated
with reduction in ROS production and oxidative stress markers, an
increased antioxidant response and preservation of mitochondria
function. Finally, Ghosh et al. [34] reported in this 5/6NX model
that curcumin (75 mg/kg/day for 8 weeks) blocks overexpression
of inﬂammatory mediators such as TNF-α and interleukin 1β (IL-
1β) through activation of phospholipase 2 (PLP2) and COX-2, both
key regulators of inﬂammation and oxidative stress inductors.
Renal injury induced by ischemia and reperfusion (I/R) or by
glomerulonephritis
The effect of curcumin on acute kidney injury induced by I/R
also has been studied. This renal injury may be consequence of
several factors as renal transplantation and involves vascular
factors and tubular damage associated with high signiﬁcant
morbidity and mortality. Curcumin was administered orally to rats
(200 mg/kg/day for 7 days) subjected to bilateral renal ischemia
for 45 min followed by 24 h reperfusion [15]. Curcumin signiﬁ-
cantly attenuated the reduction of serum GPx and the levels of
urea, cystatin C, and MDA in serum and the increase of the MDA
concentration, nitric oxide and protein carbonyl content in kidney
of rats with I/R [15]. On the other hand, Jacob et al. [41] observed,
in mice with deﬁcient immune response and glomerulonephritis
injury, that curcumin administration reduces GS and improves
renal function (evaluated by BUN and albuminuria), which was
associated to a decrease in inﬂammatory markers (TGF-β and
MCP-1) and matrix proteins (ﬁbronectin, laminin and collagen).
Shock-wave lithotripsy (SWL)
SWL is commonly used for treatment of renal stones and ROS
are involved in the pathophysiology of renal injury due to SWL. The
protective effect of curcumin (75 mg/kg/day for 35 days) against
renal injury induced by SWL was studied in Sprague-Dawley rats
[14]. Curcumin prevented interstitial, glomerular, tubular epithelial
and endothelial cellular injuries by decreasing of iNOS and p65 (the
active subunit of NF-κB) expression and serum nitric oxide levels.
This protective effect was also associated with increased levels of
GSH and attenuation of high levels of MDA in kidney [14].
Triiodothyronine (T3)-induced renal injury
One of the most important effects of thyroid hormones (T3 and
T4) is the elevation of mitochondrial respiration, producing a hyper-
metabolic state with excess generation of free radicals, Thyroxine has
been reported to induce renal hypertrophy with a rise in the DNA
content. However, there is a paucity of information on T3-induced
oxidative damage to mammalian kidney in general and with respect
to antioxidant treatment in particular [66].The effect of curcumin
treatment (30 mg/kg/day for 15 days) was evaluated on renal
damage and oxidative stress induced by T3 administration. It was
found that curcumin was able to attenuate the mitochondrial lipid
peroxidation, the enhanced SOD activity and the histopathological
changes secondary to T3-administration [66].
Renal injury induced by drugs
Cisplatin and oxaliplatin
Cisplatin is an effective anticancer drug used against lung,
ovarian cancer and some lymphomas, however renal damage has
limited its use. It has been well established that oxidative stress is
one of the mechanisms involved in cell damage induced by
cisplatin. Indeed, a decrease of antioxidant defense is clearly
observed in vivo and in vitro experimental models [19]. Antunes
et al. [9] reported curcumin administration (8 mg/kg before and
after cisplatin injection) provided protection against cisplatin
induced neurotoxicity, ototoxicity and nephrotoxicity (evaluated
by serum creatinine and creatinine clearance) and oxidant stress
(evaluated by MDA and GSH levels) in rats. Moreover, Kuhad et al.
[45] designed a two-day curcumin pretreatment and in parallel
treatment of 15, 30 and 60 mg/kg of curcumin in a model of
cisplatin-induced nephrotoxicity. The cisplatin-treated group that
received 60 mg/kg of curcumin showed normal renal function
(evaluated by measuring urea levels and creatinine clearance),
which correlated with lipid peroxidation reduction. Interestingly,
curcumin administration in cisplatin-treated animals attenuated,
in a dose dependent manner, the cisplatin-induced decrease in
GSH, SOD and CAT [45]. In addition, Ueki et al. [82] studied the
effect of curcumin administration (100 mg/kg ip) on the inﬂam-
matory mechanisms involved in the pathogenesis of cisplatin-
induced renal injury in mice. Curcumin prevented cisplatin-induce
tubular necrosis, decreased renal dysfunction and the increase of
pro inﬂammatory markers including of TNF-α in serum, and TNF-α
and MCP-1 in renal tissue, and a rising of intracellular adhesion
molecule 1 (ICAM-1) mRNA in kidney. Oxaliplatin, another
platinum-based chemotherapeutic agent can induce renal damage
and oxidant stress. In vitro studies performed by Waly et al. [84]
showed that oxaliplatin or cisplatin induced oxidative stress in
human embryonic kidney cells (HEK 293). These cells also showed
a decrease in total antioxidant capacity (TAC) and inhibition of the
activity of SOD, CAT and GPx. Interestingly, curcumin added to
these cell cultures signiﬁcantly restored TAC and activity of the
above mentioned antioxidant enzymes. Together, these studies
clear up the ability of curcumin to decrease oxidative stress
through modulation of those enzymes.
Gentamicin
Gentamicin is an aminoglycoside used in the treatment of
infections caused by Gram-negative bacteria that induces renal
injury as a side effect. Curcumin treatment (200 mg/kg/day for 10
days) ameliorated the gentamicin-induced nephrotoxicity in rats
[7]. Moreover, Manikandan et al. [50] observed a renoprotective
effect after curcumin administration (200 mg/kg/day for 7, 15 and
30 days) in gentamicin-treated animals. Nephrotoxicity was evi-
denced by increased serum creatinine and BUN. An increase in
ROS and renal lipoperoxidation and a reduction in GSH and in the
antioxidant enzymes GPx, GST, SOD and CAT were related to the
impaired glomerular ﬁltration. The degree of these alterations was
diminished in animals treated with curcumin. Furthermore, cur-
cumin modulated the inﬂammatory response in gentamicin-trea-
ted rats through NF-κB expression in a time-dependent manner
[50].
Cyclosporin A (CsA)
CsA is widely used as immunosuppressant drug in organ trans-
plantation to prevent rejection. This therapeutic agent induces renal
damage as side effect. Tirkey et al. [81] showed that curcumin was
effective by protecting CsA-induced damage, since animals that
received the phenolic compound plus CsA did not show renal
function deterioration or depletion of antioxidant enzymes. CsA
increased the thiobarbituric acid reactive substances (TBARS),
decreased renal endogenous antioxidant enzymes and deteriorated
the renal function as assessed by increased serum creatinine, BUN
and decreased creatinine and urea clearance. Curcumin reduced
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elevated levels of TBARS, attenuated renal dysfunction, increased the
levels of antioxidant enzymes and normalized the altered renal
morphology in CsA treated rats.
Adriamycin (doxorubicin)
Adriamycin is a chemotherapeutic drug that may induce nephro-
toxicity as a side effect. Treatment with curcumin (200 mg/kg/day in
1% gum acacia for 30 days) markedly protected against adriamycin-
induced proteinuria, albuminuria, hypoalbuminaemia and hyperlipi-
demia. Furthermore, curcumin also reduced urinary levels of the
enzyme N-acetyl-β-D-glucosaminidase (NAG), a marker of tubular
damage [83].
Chloroquine
Chloroquine is a drug used in the malaria treatment and
induces renal injury and oxidant stress as secondary effect. It
was found that THU (80 mg/kg/day for 15 days) and curcumin
treatment prevents chloroquine-induced nephrotoxicity and lipid
peroxidation and also the decrease in the antioxidants vitamin C,
vitamin E, SOD, CAT and GPx in kidneys of these rats [60].
Renal injury induced by chemicals
Sodium ﬂuoride (NaF)
Renal damage induced by chemicals also has drawn attention.
Nabavi et al. [54] reported the renoprotective effect of curcumin
(10 and 20 mg/kg) in rats with nephrotoxicity induced by NaF.
Renal damage in these rats relies on an impairment of renal
function evidenced by increased serum creatinine and BUN and
structural impairment due to interstitial edema, inﬂammation and
ﬁbrosis which was associated with increased nitric oxide, per-
oxides, ROS and MDA. On the other hand, curcumin treated
animals showed an improvement in renal function and showed
less histological damage associated to restoration of SOD and CAT
activities and increased GSH levels.
Heavy metals
Studies evaluating the effect of curcumin in experimental
models of nephrotoxicity by heavy metals such as chromium (Cr)
[51], cadmium [30] and mercury (Hg) [1] have been conducted.
Curcumin treatment attenuated renal dysfunction, oxidative stress
and the decrease in antioxidant enzymes induced by metals.
Interestingly, Molina-Jijón et al. [51] demonstrated that curcumin
has a protective effect against nephrotoxicity induced by hexavalent
chromium (Cr VI), and this property was related to the nuclear
translocation of Nrf2, prevention of oxidant stress and preservation
of the activity of antioxidant enzymes and of mitochondrial func-
tion in the kidney. In this study, a pretreatment of 10-day with
400 mg/kg of curcumin attenuated the structural and functional
damage to the kidney which was associated with the prevention of
mitochondrial oxidant stress and of the decrease in the following
mitochondrial determinations: oxygen consumption (state 3),
respiratory control, ATP content, calcium retention and membrane
potential. Also curcumin prevented the decrease in the following
enzymatic activities: aconitase, antioxidant enzymes and mitochon-
drial respiratory complexes I, II, II–III and V [51], (Fig. 3). This was
the ﬁrst demonstration that the prevention of renal injury was
associated to the preservation of mitochondrial function.
Fig. 3. Curcumin is able to prevent mitochondrial dysfunction associated to renal
injury. Curcumin is able to prevent lipid peroxidation and the decrease in the
following mitochondrial determinations: oxygen consumption, activity of com-
plexes I, II, II-III and V, activity of aconitase and antioxidant enzymes, GSH content,
membrane potential, calcium retention and ATP content [51]. GSH (Glutathione),
SOD (superoxide dismutase), CAT (catalase), GPx (glutathione peroxidase), GST
(glutathione-S-transferase), GR (glutathione reductase), NADþ (nicotinamide ade-
nine dinucleotide), NADH (nicotinamide adenine dinucleotide, reduced form),
FADþ (ﬂavin adenine dinucleotide), FADH2 (ﬂavin adenine dinucleotide, reduced
form), ATP (adenosine triphosphate), ADP (adenosine diphosphate).
Fig. 4. Curcumin is able to prevent several mechanisms leading to renal injury.
Curcumin renoprotective effects have been associated with the prevention of three
main factors, ﬁrst the reduction of oxidative stress by (a) preventing the generation
of O2∙ and scavenging different reactive oxygen species, and (b) by preventing the
Nrf2 degradation by ubiquitin proteosoma pathway, thus an increase of many
antioxidant enzymes. Curcumin has been shown also to be able to reduce
inﬂammatory process by reducing the inﬂammatory transcription factors such as
NF- κB and TNF-α. On the other hand the reduction of cytokines such as TGF-β or
CTGF eventually prevents a ﬁbrotic process. ROS (reactive oxygen species), O2-∙
(superoxide),∙OH (hydroxyl radical), H2O2 (hydrogen peroxide), ONOO (Peroxyni-
trite), 1O2 (Singlet oxygen), NO∙ (Nitric oxide), ROO∙ (peroxyl radical), Nrf2
(translocation of nuclear factor erythroid-derived 2), ARE (Antioxidant responsive
elements), Keap1 (Kelch-like ECH-associated protein 1), Cul3 (cullin 3), Nedd8
(Neural precursor cell expressed developmentally down-regulated 8), u (ubiquitin),
SOD (superoxide dismutase), CAT (catalase), GPx (glutathione peroxidase), GST
(glutathione-S-transferase), GCL (glutathione-cystein-ligase), TrX (thioredoxin),
TGF-β (factor transforming growth beta), CTGF (connective tissue growth factor),
NF- κB (nuclear factor kappa-light-chain-enhancer of activated B cells), TNF-α
(tumor necrosis factor), PKC (protein kinase C), PI3K (phosphoinositol 3-kinase),
PERK (protein kinase RNA-like endoplasmic reticulum kinase) MAPK (mitogen-
activated protein kinase), CK2 (Casein kinase2).
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Ferric nitrilotriacetate
Ferric nitrilotriacetate is a carcinogen and strong inductor of renal
oxidative stress. The effect of curcumin and THU on ferric nitrilo-
triacetate induced oxidant stress in male ddY mice was studied [55].
Animals were fed along four weeks with 0.5% curcumin or 0.5% THU
before the administration of ferric nitrilotriacetate. Curcumin inhib-
ited 4-hydroxy-2-nonenal-modiﬁed protein formation and THU
inhibited lipid peroxidation and renal abundance of 4-hydroxy-2-
nonenal (4-HNE, a marker of lipid peroxidation)-modiﬁed proteins
and 8-hydroxy-2′-deoxyguanosine (a marker of DNA damage).
THU induced GPx, GST and NQO1, as well as or better than curcumin.
Final remarks
According to epidemiological evidence, acute renal injury is a
serious health and economical problem across the world with
increasing cases since this disease can have its own etiology but also
can be a complication from other diseases or can be a side effect from
several medical treatments. The urgency to develop renoprotective
strategies sets the eyes in compounds as curcumin, which has been
used in the traditional medicine, speciﬁcally because its protective
effects against renal damage. In this context, the experiments of Tapia
et al. [80], in which curcumin was able to revert established renal
injury and systemic alterations in rats with 5/6NX, are promising.
At cellular andmolecular levels, recent studies have demonstrated that
this compound attenuates ROS generation and activates signaling
pathways that involve the release of Nrf2 from Keap1, promoting
transcription of genes that induce the expression of antioxidant
system (GPx, GST, CAT, and SOD). Also, recent evidence shows that
improvement of mitochondrial dysfunction induced during nephro-
toxicity seems to be a key mechanism in curcumin protection and
indirect reduction of ROS production through mechanisms including a
decrease of O2 ∙ through the down regulation of expression of some
NADPH oxidase subunits such as p67phox, p22phox and NOX4
essential for O2
̄∙ generation, which is useful against inﬂammation, a
common process during kidney injury. In this regard, curcumin also
diminishes the expression of NF-κB and TNF-α, TGF-β, extracellular
matrix proteins collagen type IV, ﬁbronectin and growth factors such
as CTGF. These proteins are closely involved not only in inﬂammation
but also, in the remodeling tissue which leads to renal ﬁbrosis. Fig. 4
and Table 1 summarize some cell protection mechanisms of curcumin
in renal damage. The information presented in this paper identiﬁes
curcumin as a promising renoprotective molecule against renal injury.
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